Metastatic Breast Cancer Program

from 2018

Patients with metastatic breast cancer and their loved ones gathered October 20, 2018 for a full day of education, support, and companionship. Below are some highlights from the annual forum, directed by Nancy Lin, MD, and sponsored by Dana-Farber's Susan F. Smith Center for Women's Cancers and EMBRACE (Ending Metastatic Breast Cancer for Everyone).

Nancy Lin, MD, and Eric P. Winer, MD, welcome attendees to the 2018 Metastatic Breast Cancer Forum and discuss research advances in the care and treatment of patients with metastatic breast cancer.

Erica Mayer, MD, MPH, and Nikhil Wagle, MD, outline the research advances in the treatment of estrogen receptor positive (ER+) breast cancer.

Nancy Lin, MD, and Geoffrey Shapiro, MD, PhD, review treatment and research advances in the treatment of triple negative breast cancer.

Heather Parsons, MD, MPH, and Ian Krop, MD, PhD, discuss the future of treating metastatic HER2+ breast cancer and how clinical trials help make progress in finding new therapies.

The panelists Jennifer Ligibel, MD, James Tulsky, MD, Nancy Lin, MD, and Julie Salinger, MSW, LICSW, discuss symptoms management and answer questions from the audience.

Huma Rana, MD, provides an overview of genetic testing and its practical applications.

Heather Parsons, MD, MPH, summarizes research advances in liquid biopsies and their potential for use in the diagnosis and treatment of breast cancer.

Sara Tolaney, MD, MPH, and Adrienne Waks, MD, provide an overview of clinical trials, including why they are necessary and how to participate in them.